Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
filingDate |
2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb76c60487c2c0ac4c44b6328260640e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64c252397804123d7b339fb173296d12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe98bf148d556fecdd2e9d818c8a7726 |
publicationDate |
2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013219147-A1 |
titleOfInvention |
Uses of DPP-IV inhibitors |
abstract |
Disclosed is the use of selected DPP-IV inhibitors for treating physiological functional disorders and reducing the risk of at-risk patient groups developing such functional 5 disorders. Also disclosed is the use of said DPP-IV inhibitors in combination with other agents such that improved treatment results can be obtained. Said uses can be employed for producing corresponding medicaments. |
priorityDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |